{"name":"Guangdong Zhongsheng Pharmaceutical Co., Ltd.","slug":"guangdong-zhongsheng-pharmaceutical-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":5,"colorKey":"oncology","drugs":[{"name":"ZSP1241","genericName":"ZSP1241","slug":"zsp1241","indication":"Other","status":"phase_1"},{"name":"ZSP1601 50 mg","genericName":"ZSP1601 50 mg","slug":"zsp1601-50-mg","indication":"Other","status":"phase_1"},{"name":"ZSP1273 High Dose","genericName":"ZSP1273 High Dose","slug":"zsp1273-high-dose","indication":"Other","status":"phase_1"},{"name":"ZSP1273 Median Dose","genericName":"ZSP1273 Median Dose","slug":"zsp1273-median-dose","indication":"Other","status":"phase_1"},{"name":"ZSP1601 25 mg","genericName":"ZSP1601 25 mg","slug":"zsp1601-25-mg","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"ZSP1241","genericName":"ZSP1241","slug":"zsp1241","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ZSP1601 50 mg","genericName":"ZSP1601 50 mg","slug":"zsp1601-50-mg","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ZSP1273 High Dose","genericName":"ZSP1273 High Dose","slug":"zsp1273-high-dose","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ZSP1273 Median Dose","genericName":"ZSP1273 Median Dose","slug":"zsp1273-median-dose","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ZSP1601 25 mg","genericName":"ZSP1601 25 mg","slug":"zsp1601-25-mg","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxOOW11R1NFLXFJT0Z6Q0hhdTBXTUM4eTRwQV9RcF9rYll2UnJuUHZiU2hqYzg2T3BncG5jcnNYekxQdFE1VTRvc2hRNGc0NkdSallKX0ZxWTF3bDExb05TcXFXV2w1bGdqU2F5ZE4tZWZIMUtpR1VLR0lvT0Fnb0p5bXNtLUFLLXJha1YyTUFZaHFHT2h0ejg3UzJmczBjUlBpbmhnNlRqX2hRdUxqZnZ0VFBHR2hsX21lcjh2c2Z5OA?oc=5","date":"2026-03-30","type":"pipeline","source":"Markets Mojo","summary":"Guangdong Zhongsheng Pharmaceutical Hits Day High with 5.46% Surge - Markets Mojo","headline":"Guangdong Zhongsheng Pharmaceutical Hits Day High with 5.46% Surge","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxPRHFxNU1VRDBKdU9sUWxhRFJTZ2tzTU5XSnRGR0tSNk1mY3lCQ1BRYmtsc0VxSEFscDdLZm9UdU9kOUY4OVlMU3NPRnVJMVJFOHR0cFJ5d2VUWG1sZThQV0IzQXgybGNGZW9sbW9lbUxvOF84Nmt5dlpWRzFjRHozdkxpcUNZTGFlTE9hc0ZsRDBLblRBUFVsV2loeXV5ODJ4cUl3cjFSOXY4cXV2bUE?oc=5","date":"2026-03-28","type":"pipeline","source":"富途牛牛","summary":"The landscape for innovative drugs is shifting: off-hospital channels have become the main battleground, with consumer-oriented products on the rise. - 富途牛牛","headline":"The landscape for innovative drugs is shifting: off-hospital channels have become the main battleground, with consumer-o","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxOVVd5Mzk5b3BldDUtVk95eC1TUGs4cUE4MkczWTZhRks1MXVOMXk1d2NtNkFoaFpXeEpQRW5YcnBtUUh5RFA3MmU2RzZ0ZmxZVG1iRld3QUxBTDRzc0dITnowbzRSS05CNmpEaVhJRmVJMG5YSXJ1eDBSdUw1THpLLVZZMXdLbDJPZ21YeW9GNDJKcFMtQ1JNMXZyNUlIaTlxQWtEU1pHS19FMXh2azV3bDFhMEhJbDUwVUg3czdTM01HVWR4UmwwVTF5RTJJMXhNZGo5Zw?oc=5","date":"2026-03-26","type":"pipeline","source":"Markets Mojo","summary":"Guangdong Zhongsheng Pharmaceutical Hits Day Low Amid Price Pressure at CNY 16.60 - Markets Mojo","headline":"Guangdong Zhongsheng Pharmaceutical Hits Day Low Amid Price Pressure at CNY 16.60","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPdnhKSzVZdTJmSmZnb2k0d0I3d3hxaUZTN3NmUlQ4bWlxWTdBdTZCd0ZaYk9QWG1BTTI0S2F2SzhSQW9TMVN6emswcDN4cTU0d3c0cjNxRG1fRkc0eDhPLUVLdGUzVnFocjZUUnI4cGxFTkhtTXVsUVE4SGpHWjhmelpNLWV1Q09tV1Z5Szh0aFNraDRXcm5BcXkweVBxUzFOV3M1bmc4V3FuR2RJNDBqQ3JsWTN0WU5vOXU1NEVxUQ?oc=5","date":"2026-03-26","type":"pipeline","source":"Markets Mojo","summary":"Guangdong Zhongsheng Pharmaceutical Hits Day High with 4.49% Surge - Markets Mojo","headline":"Guangdong Zhongsheng Pharmaceutical Hits Day High with 4.49% Surge","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTFBQUDg4Wl9KX1Yxdi1vMm5kcy1pUFhvRkFTbmRGaVgweFB6Yi1TaWZudnVfSmpsYjVaUklZVUx2Y3dWcmhSdFlQTk8yZGZwU0w0anRpbE5VOVlSSTJaWnZyYTFTT1ZKamxzWENyejlwOTdVZVJYai12TGJIbmpCY2s?oc=5","date":"2025-12-09","type":"pipeline","source":"State Council Information Office","summary":"China makes new, innovative drugs more accessible, affordable - State Council Information Office","headline":"China makes new, innovative drugs more accessible, affordable","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxPRFFiOHBpZ2p5S3dfc0E3T1hLNlpCVGpIQkxEU05KejcwZ3RsN3B6NndNWTVwa3VuX2dqLXpJUVpkTElWMGdnVWl6c1pXVzc3S0pDZTJOUXdNNV9jUklVVGxCZlBPMEw2bDY4YTJxQngwYTlnUG5QLW12ZVBlb2cyTDRQa0N3NnJmY3JPNHZwU3laUjEyUlY2eC1FSEw0VWJ2Nk9EYW9qOEsyWVVaU1hVazhYMzNZam5zbnpDaVlyd2QzSV8tRVZFMmx3?oc=5","date":"2023-03-24","type":"regulatory","source":"Yicai Global","summary":"Zhongsheng Pharma Falls Despite Conditional Market Approval for Unit’s 3CL Oral Covid Drug - Yicai Global","headline":"Zhongsheng Pharma Falls Despite Conditional Market Approval for Unit’s 3CL Oral Covid Drug","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxQbnFfbDU2Vlc0ZW9BcnItOVEta2p2eVBmM3FaaFFERG5CS0tRd2JBd2ZtWXNOd0lXMEZYNG55LS1SaF82T3ltWDFnV2JVQmQzODJjT0RHSGdDOS1LcGJzemZzV2I2cjI1NnVEV0FFSFBKQXhVT05xZlhQQmxWMGNzTjYyOUtnUHczRGdCaTlCQjdjZ3FpbTZyaXZDdktWeWVKc09feVNtbVc5bEVGS09PR29ZSk52Z0t3UkhvbHFDZ2UtWHh3YklxYk45RUo3c1UtOUVZX0FILVozU1MzZTFfREZaYmo1dw?oc=5","date":"2022-08-31","type":"pipeline","source":"PR Newswire","summary":"Influenza Pipeline Looks Promising as 100+ Companies Working in the Domain, Assesses DelveInsight - PR Newswire","headline":"Influenza Pipeline Looks Promising as 100+ Companies Working in the Domain, Assesses DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWkFVX3lxTE03bF9GV0poTXF3UWVHbTl1SHBnbmxyVjIwYjUzOW9aZkhsREVJejhYOW1ibzBHV2RYUVFDODlRRVFtS2x0cFZnWWg2X3U5Y212Z3N4YTNMTkRPQQ?oc=5","date":"2017-05-19","type":"pipeline","source":"nature.com","summary":"Therapeutic potential of an anti-HER2 single chain antibody–DM1 conjugates for the treatment of HER2-positive cancer - nature.com","headline":"Therapeutic potential of an anti-HER2 single chain antibody–DM1 conjugates for the treatment of HER2-positive cancer","sentiment":"neutral"}],"patents":[],"drugCount":5,"phaseCounts":{"phase_1":5},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}